In the first reported RT-QuIC-like assay for tau, Meyer et al. (2014) [31] were able to detect the aggregation of synthetic monomeric tau using either synthetic tau fibrils or homogenized human AD brain as a seed. This evidence concerns the gene MAPT and Alzheimer disease.